178 related articles for article (PubMed ID: 12766786)
1. Botulinum toxin as a preventive treatment for migraine and chronic tension headache.
Cattin T
N Z Med J; 2003 May; 116(1174):U440. PubMed ID: 12766786
[No Abstract] [Full Text] [Related]
2. Botulinum toxin type A for the treatment of headache: why we say yes.
Ashkenazi A; Silberstein S
Arch Neurol; 2008 Jan; 65(1):146-9. PubMed ID: 18195155
[No Abstract] [Full Text] [Related]
3. BOTOX for headache treatment.
Rothrock JF
Headache; 2007 Feb; 47(2):345-6. PubMed ID: 17300388
[No Abstract] [Full Text] [Related]
4. Duration of migraine is a predictor for response to botulinum toxin type A.
Eross EJ; Gladstone JP; Lewis S; Rogers R; Dodick DW
Headache; 2005 Apr; 45(4):308-14. PubMed ID: 15836566
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin in tension-type headache.
Relja M; Telarović S
J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type A for the treatment of headache: con.
Welch KM
Headache; 2004 Sep; 44(8):831-3. PubMed ID: 15330835
[No Abstract] [Full Text] [Related]
7. [Botulinum: fashionable drug and effective medication. What the "miracle weapon against crow's feet" can do in addition].
Stiefelhagen P
MMW Fortschr Med; 2003 Apr; 145(14):4-6. PubMed ID: 15072266
[No Abstract] [Full Text] [Related]
8. Botox therapy for refractory chronic migraine.
Conway S; Delplanche C; Crowder J; Rothrock J
Headache; 2005 Apr; 45(4):355-7. PubMed ID: 15836573
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Type A in the treatment of chronic migraine without medication overuse.
Freitag FG; Diamond S; Diamond M; Urban G
Headache; 2008 Feb; 48(2):201-9. PubMed ID: 18042229
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
Schulte-Mattler WJ; Krack P;
Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin in migraine prophylaxis.
Göbel H
J Neurol; 2004 Feb; 251 Suppl 1():I8-11. PubMed ID: 14991336
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tension-type headache with botox: a review of the literature.
Rozen D; Sharma J
Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type A in chronic migraine.
Freitag FG
Expert Rev Neurother; 2007 May; 7(5):463-70. PubMed ID: 17492897
[TBL] [Abstract][Full Text] [Related]
15. Predicting migraine responsiveness to botulinum toxin type A injections.
Kim CC; Bogart MM; Wee SA; Burstein R; Arndt KA; Dover JS
Arch Dermatol; 2010 Feb; 146(2):159-63. PubMed ID: 20157026
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A for the treatment of headache: pro.
Blumenfeld A
Headache; 2004 Sep; 44(8):825-30. PubMed ID: 15330834
[No Abstract] [Full Text] [Related]
17. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A. An alternative treatment for migraine.
Moses LL
Adv Nurse Pract; 2009 Dec; 17(12):40-1. PubMed ID: 20014704
[No Abstract] [Full Text] [Related]
19. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
